A successful drug or biological is one that has all the components of reimbursement working – coverage, coding, payment and access. DKP is well-known for its thoughtful strategic approach to reimbursement for oncology and rare diseases that doesn’t only provide a 10,000 foot view, but also an understanding of how care is delivered at the patient level. This means identifying the implications to providers, payers, and patients.

No matter whether you are assessing a licensing opportunity, preparing for and launching a new asset, or managing a more mature product, DKP can effectively support corporate objectives. Whether through the DKP Lifecycle Solutions™ strategic consulting services, or DKP PayerScope® market monitoring services, DKP connects you with the important information required to understand and act – no matter what phase of life your product is in.

As you develop new products that offer novel or additional patient health outcomes, DKP creates and communicates a clear understanding of the reimbursement environment that you are entering. In early development, we may even help to guide which market to enter as some pose more challenging reimbursement obstacles than others. The DKP Lifecycle Solutions™ strategic consulting team maps out the market expectations and trending drivers for change, so you can develop effective planning strategies, whether acquiring a drug or developing an internal asset, and prepare for market conditions to ensure patient access to new therapeutics and supportive care agents.

As a product nears market commercialization, the DKP team evaluates clinical trial outcomes and determines the product’s and company’s strengths and weakness and the impact that they may have on payer uptake, provider reimbursement, patient cost share, and patient access. Using qualitative research (live advisory forums or in-depth interviews) or quantitative survey approaches, we capture timely information on feedback for crafting product value propositions. DKP not only creates the big picture but takes the level of understanding down to the local implementation level: what you need to understand geographic variances, payer type nuances, and decision maker needs.

DKP Lifecycle Solutions™ offers a turn-key launch solution that has a solid track record. We understand what makes a difference to gain market uptake, whether the product is applied to complex orphan/ultra-orphan conditions, or encompasses the nuances between payer management of physician-administered and self-administered oncology agents. Our role is to provide a clear path and timing for that process, anticipating potential challenges – and opportunities – along the way. The DKP team expertise encompasses such launch roles as:

Pricing compendia uptake

Clinical compendia strategies

National CMS positioning

Local Medicare Administrative Contractor (MAC) coverage

Medicaid coverage and access development

Commercial payer positioning

Our success with product launch is what keeps many clients such as yourself coming back with subsequent pipeline assets.

The unknown in the market after launch is understanding what actions the payers are taking related to your product. Through the application of DKP PayerScope® market monitoring, you can track payer uptake, related to relevant endpoints such as:

Formal published policy

Prior authorization status and criteria

Utilization management criteria

Specialty pharmacy program integration

Formulary positioning

Comparator product parity

Whether Medicare, Medicaid, or commercial payers, DKP PayerScope® market monitoring can be the eyes and ears of your company to make sure you know where your product stands. Not forgetting other stakeholders in the market, DKP will consistently gather insights from providers, employers, and other market drivers to help paint a picture of the market as it is. During this phase, the DKP Lifecycle Solutions™ team uses all the cumulative data to help perform trending analytics and determine what might come around the next corner that you need to prepare for.